These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


200 related items for PubMed ID: 36222855

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Response Prediction Using 18F-FAPI-04 PET/CT in Patients with Esophageal Squamous Cell Carcinoma Treated with Concurrent Chemoradiotherapy.
    Hu X, Zhou T, Ren J, Duan J, Wu H, Liu X, Mu Z, Liu N, Wei Y, Yuan S.
    J Nucl Med; 2023 Apr; 64(4):625-631. PubMed ID: 36229183
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prognostic value of baseline 18F-FDG PET/CT in patients with esophageal squamous cell carcinoma treated with definitive (chemo)radiotherapy.
    Xia L, Li X, Zhu J, Gao Z, Zhang J, Yang G, Wang Z.
    Radiat Oncol; 2023 Feb 24; 18(1):41. PubMed ID: 36829219
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of preoperative [68 Ga]Ga-FAPI-04 PET/CT in patients with resectable pancreatic ductal adenocarcinoma in correlation with immunohistological characteristics.
    Ding J, Qiu J, Hao Z, Huang H, Liu Q, Liu W, Ren C, Hacker M, Zhang T, Wu W, Huo L, Li X.
    Eur J Nucl Med Mol Imaging; 2023 May 24; 50(6):1780-1791. PubMed ID: 36695823
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prognostic Implications of 68Ga-FAPI-46 PET/CT-Derived Parameters on Overall Survival in Various Types of Solid Tumors.
    Watanabe M, Fendler WP, Grafe H, Hirmas N, Hamacher R, Lanzafame H, Pabst KM, Hautzel H, Aigner C, Kasper S, von Tresckow B, Stuschke M, Kümmel S, Lugnier C, Hadaschik B, Grünwald V, Zarrad F, Siveke JT, Herrmann K, Weber M.
    J Nucl Med; 2024 Jul 01; 65(7):1027-1034. PubMed ID: 38782454
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Evaluation of Advanced Lung Cancer.
    Wang L, Tang G, Hu K, Liu X, Zhou W, Li H, Huang S, Han Y, Chen L, Zhong J, Wu H.
    Radiology; 2022 Apr 01; 303(1):191-199. PubMed ID: 34981976
    [Abstract] [Full Text] [Related]

  • 11. The added value of [68Ga]Ga-DOTA-FAPI-04 PET/CT in pancreatic cancer: a comparison to [18F]F-FDG.
    Liu Q, Shi S, Liu S, Xu X, Hu S, Zhang J, Wang C, Yu X, Song S.
    Eur Radiol; 2023 Jul 01; 33(7):5007-5016. PubMed ID: 36809431
    [Abstract] [Full Text] [Related]

  • 12. Diffusion-weighted MRI and 18F-FDG PET/CT in assessing the response to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma.
    Xu X, Sun ZY, Wu HW, Zhang CP, Hu B, Rong L, Chen HY, Xie HY, Wang YM, Lin HP, Bai YR, Ye Q, Ma XM.
    Radiat Oncol; 2021 Jul 19; 16(1):132. PubMed ID: 34281566
    [Abstract] [Full Text] [Related]

  • 13. Accurate preoperative staging with [68Ga]Ga-FAPI PET/CT for patients with oral squamous cell carcinoma: a comparison to 2-[18F]FDG PET/CT.
    Chen S, Chen Z, Zou G, Zheng S, Zheng K, Zhang J, Huang C, Yao S, Miao W.
    Eur Radiol; 2022 Sep 19; 32(9):6070-6079. PubMed ID: 35352157
    [Abstract] [Full Text] [Related]

  • 14. PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using 68Ga-FAP-2286: Comparison with 18F-FDG and 68Ga-FAPI-46 in a Single-Center, Prospective Study.
    Pang Y, Zhao L, Meng T, Xu W, Lin Q, Wu H, Zhang J, Chen X, Sun L, Chen H.
    J Nucl Med; 2023 Mar 19; 64(3):386-394. PubMed ID: 36215571
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The prognostic value of positron emission tomography/computed tomography-based parameters in locally advanced esophageal squamous cell carcinoma treated with chemoradiation therapy.
    Zhang W, Jia H, Cheng Z, Diao W, Wang Y, Cao B, Kou Y, Wang Q.
    Nucl Med Commun; 2022 Dec 01; 43(12):1239-1246. PubMed ID: 36345769
    [Abstract] [Full Text] [Related]

  • 20. Positron emission tomography and computed tomography with [68Ga]Ga-fibroblast activation protein inhibitors improves tumor detection and staging in patients with pancreatic cancer.
    Pang Y, Zhao L, Shang Q, Meng T, Zhao L, Feng L, Wang S, Guo P, Wu X, Lin Q, Wu H, Huang W, Sun L, Chen H.
    Eur J Nucl Med Mol Imaging; 2022 Mar 01; 49(4):1322-1337. PubMed ID: 34651226
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.